Stay updated on TRuE AD1 Clinical Trial
Sign up to get notified when there's something new on the TRuE AD1 Clinical Trial page.

Latest updates to the TRuE AD1 Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedStudy record page now displays a 403 Forbidden error, replacing the previously visible study details and related content. This blocks access to the trial's core information including objectives, eligibility criteria, and locations.SummaryDifference21%

- Check19 days agoChange DetectedThe revision tag on the page has been updated to v3.7.0, replacing the previous v3.6.6. This denotes a newer documentation version but does not change the study details or data.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, signaling that a new build of the page was released.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page gained an NIH funding note—'2018 ( U.S. NIH Grant/Contract )'—added next to the EudraCT number in the Study Details area, documenting the U.S. funding source for the trial.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a new version of the page. This version update represents an internal update to the page metadata and doesn't change the user-facing content of the study record.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a small update to the page's documentation/versioning. There are no changes to the study details or related content.SummaryDifference0.0%

Stay in the know with updates to TRuE AD1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TRuE AD1 Clinical Trial page.